Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Flavonoids and asthma.

Tanaka T, Takahashi R.

Nutrients. 2013 Jun 10;5(6):2128-43. doi: 10.3390/nu5062128. Review.

2.

Flavonoids for allergic diseases: present evidence and future perspective.

Tanaka T.

Curr Pharm Des. 2014;20(6):879-85. Review.

PMID:
23701574
3.

Flavonoids and related compounds as anti-allergic substances.

Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, Ohkawara T, Hagihara K, Yamadori T, Shima Y, Ogata A, Kawase I, Tanaka T.

Allergol Int. 2007 Jun;56(2):113-23. Epub 2007 Mar 1. Review.

4.

Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils.

Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, Kawase I, Tanaka T.

J Allergy Clin Immunol. 2003 Jun;111(6):1299-306.

PMID:
12789233
5.

Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils.

Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S, Fujimoto M, Yamadori T, Kawase I, Tanaka T.

Int Arch Allergy Immunol. 2004 Jun;134(2):135-40. Epub 2004 May 17.

PMID:
15153793
6.

Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMI™, inhibit memory Th2 responses in vitro and in vivo.

Yang N, Patil S, Zhuge J, Wen MC, Bolleddula J, Doddaga S, Goldfarb J, Sampson HA, Li XM.

Phytother Res. 2013 Sep;27(9):1381-91. doi: 10.1002/ptr.4862. Epub 2012 Nov 19.

7.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
8.

Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):227-9. Review.

PMID:
15379589
9.

IL-5 and IL-5 receptor in asthma.

Kotsimbos AT, Hamid Q.

Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91. Review.

10.

Chrysin alleviates allergic inflammation and airway remodeling in a murine model of chronic asthma.

Yao J, Jiang M, Zhang Y, Liu X, Du Q, Feng G.

Int Immunopharmacol. 2016 Mar;32:24-31. doi: 10.1016/j.intimp.2016.01.005. Epub 2016 Jan 15.

PMID:
26780233
11.

Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?

Chung KF.

Curr Opin Investig Drugs. 2003 Nov;4(11):1320-6. Review.

PMID:
14758771
12.

Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs.

Joks R, Durkin HG.

Pharmacol Res. 2011 Dec;64(6):602-9. doi: 10.1016/j.phrs.2011.04.001. Epub 2011 Apr 9. Review.

PMID:
21501686
13.

Flavonoids on allergy.

Castell M, Pérez-Cano FJ, Abril-Gil M, Franch À.

Curr Pharm Des. 2014;20(6):973-87. Review.

PMID:
23701555
14.

New insights into the role of cytokines in asthma.

Renauld JC.

J Clin Pathol. 2001 Aug;54(8):577-89. Review.

15.

Chrysin attenuates allergic airway inflammation by modulating the transcription factors T-bet and GATA-3 in mice.

Du Q, Gu X, Cai J, Huang M, Su M.

Mol Med Rep. 2012 Jul;6(1):100-4. doi: 10.3892/mmr.2012.893. Epub 2012 Apr 26.

PMID:
22552848
16.

Anti-inflammatory and anti-allergic effects of Agrimonia pilosa Ledeb extract on murine cell lines and OVA-induced airway inflammation.

Kim JJ, Jiang J, Shim DW, Kwon SC, Kim TJ, Ye SK, Kim MK, Shin YK, Koppula S, Kang TB, Choi DK, Lee KH.

J Ethnopharmacol. 2012 Mar 27;140(2):213-21. doi: 10.1016/j.jep.2011.12.035. Epub 2012 Jan 21.

PMID:
22289347
17.

Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.

Iwaki K, Ohashi E, Arai N, Kohno K, Ushio S, Taniguchi M, Fukuda S.

J Ethnopharmacol. 2011 Mar 24;134(2):450-9. doi: 10.1016/j.jep.2010.12.041. Epub 2011 Jan 7.

PMID:
21216280
19.

Attenuation of airway hyperreactivity and T helper cell type 2 responses by coumarins from Peucedanum praeruptorum Dunn in a murine model of allergic airway inflammation.

Xiong YY, Wu FH, Wang JS, Li J, Kong LY.

J Ethnopharmacol. 2012 May 7;141(1):314-21. doi: 10.1016/j.jep.2012.02.037. Epub 2012 Feb 28.

PMID:
22401763
20.

Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.

Oliver JM, Tarleton CA, Gilmartin L, Archibeque T, Qualls CR, Diehl L, Wilson BS, Schuyler M.

Int Arch Allergy Immunol. 2010;151(4):275-84. doi: 10.1159/000250436. Epub 2009 Oct 22.

Supplemental Content

Support Center